Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acceptability of chemoprevention trials in high-risk subjects.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Nov 2013

Bonanni B, Lazzeroni M

Abstract excerpt

The development and current widespread acceptance of clinical trials is one of the major conceptual advances in research medicine introduced during the second half of the 20th century. Despite general agreement on the scientific merits of randomization, many patients and physicians are however reluctant to participate in randomized, controlled trials. If we focus on chemoprevention in healthy subjects, it is even...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemoprevention

Share to Heterozygote

Share to Molecular Targeted Therapy

Share to Ovarian Neoplasms

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 24131969
DOI: 10.1093/annonc/mdt328

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acceptability of chemoprevention trials in high-risk subjects.PMID 24131969Read ↗

Cancer risk research: what should we tell subjects?Semantic proximity Read ↗

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.Semantic proximity Read ↗

Criteria to rationalize population screening to control oral cancer.Semantic proximity Read ↗

Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment.Semantic proximity Read ↗

From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters.Semantic proximity Read ↗

Is HRT justified for symptom management in women at higher risk of developing breast cancer?Semantic proximity Read ↗

Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys.Semantic proximity Read ↗

Women at a Disadvantage in Fluorouracil Treatment-Reply.Semantic proximity Read ↗

Chemoprevention of breast cancer.Semantic proximity Read ↗

An Empirical Analysis of Precision Previvorship: Are Familial and High-Risk Cancer Preventive Programs Evidence Based?Semantic proximity Read ↗

[Breast cancer screening for women with a strong familial risk].Semantic proximity Read ↗

Biomarkers and surrogacy: relevance to chemoprevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.